April 4, 2016
Timmerman Report
By Luke Timmerman
One of the big ideas in biotech today is that you can prevent severe, chronic migraineheadaches. This story has a lot of juicy ingredients: intriguing biology, bona fide medical value, and a potentially broad impact on millions of people. But if the drugmakers in this emergingcategory overplay their hand, and don’t paycareful attention to the new drug pricingreality, it could become a train wreck.
